Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Call Transcript 2023

May 19, 2023

62142_rns_2023-05-19_3fc1996f-fdd9-4376-ad2d-65f25d2d07f2.pdf

Call Transcript

Open in viewer

Opens in your device viewer

HARSHAVARD Digitally signed by HARSHAVARDHAN HAN PANIGRAHI Date: 2023.05.19 PANIGRAHI 14:25:00 +05'30'

==> picture [200 x 52] intentionally omitted <==

4QFY23 Earnings Call Marksans Pharma May 31, 2023 at 4:00 PM (IST)

==> picture [114 x 61] intentionally omitted <==

Ambit Capital cordially invites you to the 4QFY23 Earnings Call of Marksans Pharma

Company Representatives

Mr. Mark Saldanha, Founder, Chairman, and Managing Director Mr. Jitendra Sharma, Chief Financial Officer

The teleconference will be moderated by Prashant Nair, Institutional Equities, Ambit Capital. Conference Call Details

Date: May 31, 2023 | Time: 4:00 PM (IST)

Please join the conference via Diamond Pass to avoid wait time. Please click here to register.

+91 22 6280 1148 Primary Access Numbers +91 22 7115 8049 Singapore: 800 101 2045 Hong Kong: 800 964 448 International Toll Free Numbers USA: 1 866 746 2133 UK: 0 808 101 1573 We request you to dial in a few minutes prior to the scheduled time.